标题
Emerging developments of chemoradiotherapy in stage III NSCLC
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 9, Issue 10, Pages 591-598
出版商
Springer Nature
发表日期
2012-08-28
DOI
10.1038/nrclinonc.2012.135
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Are the Results of RTOG 0617 Mysterious?
- (2012) James D. Cox INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Respiration-Correlated Image Guidance Is the Most Important Radiotherapy Motion Management Strategy for Most Lung Cancer Patients
- (2012) Stine Korreman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Pulmonary Toxicity After Bevacizumab and Concurrent Thoracic Radiotherapy Observed in a Phase I Study for Inoperable Stage III Non–Small-Cell Lung Cancer
- (2012) Joline S.W. Lind et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyperfractionated or Accelerated Radiotherapy in Lung Cancer: An Individual Patient Data Meta-Analysis
- (2012) Audrey Mauguen et al. JOURNAL OF CLINICAL ONCOLOGY
- A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
- (2012) Johannes R Kratz et al. LANCET
- Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer
- (2012) Luhua Wang et al. LUNG CANCER
- A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer
- (2012) Carsten Nieder et al. Radiation Oncology
- Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology
- (2011) S. I. Jalal et al. ANNALS OF ONCOLOGY
- Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer
- (2011) Joe Y. Chang et al. CANCER
- Pulmonary Toxicity in Stage III Non-Small Cell Lung Cancer Patients Treated With High-Dose (74 Gy) 3-Dimensional Conformal Thoracic Radiotherapy and Concurrent Chemotherapy Following Induction Chemotherapy: A Secondary Analysis of Cancer and Leukemia Group B (CALGB) Trial 30105
- (2011) Joseph K. Salama et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial
- (2011) Charles Butts et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407
- (2011) Ramaswamy Govindan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Pemetrexed and Cisplatin, with Chest Radiotherapy Followed by Docetaxel in Patients with Stage III Non-small Cell Lung Cancer
- (2011) Shirish M. Gadgeel et al. Journal of Thoracic Oncology
- Benefits and Adverse Events Among Elderly Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: Analysis of the Okayama Lung Cancer Study Group Trial 0007
- (2011) Nagio Takigawa et al. Journal of Thoracic Oncology
- Treatment of the Elderly When Cure is the Goal: The Influence of Age on Treatment Selection and Efficacy for Stage III Non-small Cell Lung Cancer
- (2011) Linda E. Coate et al. Journal of Thoracic Oncology
- Respiratory Gating Techniques for Optimization of Lung Cancer Radiotherapy
- (2011) Philippe Giraud et al. Journal of Thoracic Oncology
- S-1 Plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Multi-Institutional Phase II Trial (West Japan Thoracic Oncology Group 3706)
- (2011) Yukito Ichinose et al. Journal of Thoracic Oncology
- Population-Based Estimates of Survival Benefit Associated with Combined Modality Therapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer
- (2011) Amy J. Davidoff et al. Journal of Thoracic Oncology
- Risk Factors for Treatment-Related Death Associated with Chemotherapy and Thoracic Radiotherapy for Lung Cancer
- (2011) Yuko Minami-Shimmyo et al. Journal of Thoracic Oncology
- A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531
- (2011) Gregory A. Masters et al. LUNG CANCER
- Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer
- (2011) D. Shumway et al. LUNG CANCER
- PET scans in radiotherapy planning of lung cancer
- (2011) Dirk De Ruysscher et al. LUNG CANCER
- Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: A prospective validation
- (2011) Hugo J.W.L. Aerts et al. LUNG CANCER
- Adaptive clinical trials in oncology
- (2011) Donald A. Berry Nature Reviews Clinical Oncology
- Dose escalation for non-small cell lung cancer: Analysis and modelling of published literature
- (2011) Mike Partridge et al. RADIOTHERAPY AND ONCOLOGY
- Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)
- (2011) M. Baumann et al. RADIOTHERAPY AND ONCOLOGY
- Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study
- (2011) Dirk De Ruysscher et al. RADIOTHERAPY AND ONCOLOGY
- Exploring the Genomes of Cancer Cells: Progress and Promise
- (2011) M. R. Stratton SCIENCE
- A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin–docetaxel, plus radical concurrent chemoradiotherapy with cisplatin–docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer
- (2010) S. Senan et al. ANNALS OF ONCOLOGY
- Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity
- (2010) E. C. J. Phernambucq et al. ANNALS OF ONCOLOGY
- Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer
- (2010) D. Hardy et al. ANNALS OF ONCOLOGY
- Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer
- (2010) F Oshita et al. BRITISH JOURNAL OF CANCER
- Induction Chemotherapy and Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Patients With Locally Advanced Inoperable Non–Small-Cell Lung Cancer: The MRC INCH Randomized Trial
- (2010) Matthew Hatton et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Phase II Study of Cisplatin and Irinotecan As Induction Chemotherapy Followed by Concomitant Thoracic Radiotherapy with Weekly Low-dose Irinotecan in Unresectable, Stage III, Non-Small Cell Lung Cancer: JCOG 9706
- (2010) K. Takeda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer
- (2010) Angela van Baardwijk et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007
- (2010) Yoshihiko Segawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105
- (2010) Nobuyuki Yamamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
- (2010) Anne Aupérin et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment Outcomes of Different Prognostic Groups of Patients on Cancer and Leukemia Group B Trial 39801: Induction Chemotherapy Followed by Chemoradiotherapy Compared with Chemoradiotherapy Alone for Unresectable Stage III Non-small Cell Lung Cancer
- (2010) Thomas E. Stinchcombe et al. Journal of Thoracic Oncology
- Late Complications of High-Dose (≥66 Gy) Thoracic Conformal Radiation Therapy in Combined Modality Trials in Unresectable Stage III Non-small Cell Lung Cancer
- (2010) Carrie B. Lee et al. Journal of Thoracic Oncology
- Distinctive Characteristics of Non-small Cell Lung Cancer (NSCLC) in the Young: A Surveillance, Epidemiology, and End Results (SEER) Analysis
- (2010) Janakiraman Subramanian et al. Journal of Thoracic Oncology
- Chemoradiotherapy and Gefitinib in Stage III Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor and KRAS Mutation Analysis: Cancer and Leukemia Group B (CALEB) 30106, a CALGB-Stratified Phase II Trial
- (2010) Neal Ready et al. Journal of Thoracic Oncology
- Concurrent cetuximab and radiotherapy after docetaxel–cisplatin induction chemotherapy in stage III NSCLC: Satellite—A phase II study from the Swedish Lung Cancer Study Group
- (2010) A. Hallqvist et al. LUNG CANCER
- A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non-Small Cell Lung Cancer
- (2009) R. Mutter et al. CLINICAL CANCER RESEARCH
- Escalation and Intensification of Radiotherapy for Stage III Non-small Cell Lung Cancer: Opportunities for Treatment Improvement
- (2009) J.D. Fenwick et al. CLINICAL ONCOLOGY
- Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer
- (2009) Hideyuki Harada et al. International Journal of Clinical Oncology
- Using Fluorodeoxyglucose Positron Emission Tomography to Assess Tumor Volume During Radiotherapy for Non–Small-Cell Lung Cancer and Its Potential Impact on Adaptive Dose Escalation and Normal Tissue Sparing
- (2009) Mary Feng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Influence of Technologic Advances on Outcomes in Patients With Unresectable, Locally Advanced Non–Small-Cell Lung Cancer Receiving Concomitant Chemoradiotherapy
- (2009) Zhongxing X. Liao et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Tracheoesophageal Fistula Formation in Patients With Lung Cancer Treated With Chemoradiation and Bevacizumab
- (2009) David R. Spigel et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
- (2009) Kathy S Albain et al. LANCET
- Stage IIIA-N2 NSCLC: A review of its treatment approaches and future developments
- (2009) Jan P. van Meerbeeck et al. LUNG CANCER
- Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysis
- (2009) Janneke P.C. Grutters et al. RADIOTHERAPY AND ONCOLOGY
- Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study
- (2008) D. D. Ruysscher et al. ANNALS OF ONCOLOGY
- Addressing the Current Challenges of Non–Small-Cell Lung Cancer Clinical Trial Accrual
- (2008) Walter J. Curran et al. Clinical Lung Cancer
- Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105
- (2008) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023
- (2008) Karen Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of comorbidity and age on the outcome of patients with inoperable NSCLC treated with concurrent chemoradiotherapy
- (2007) S. Semrau et al. RESPIRATORY MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now